News
Traditionally, source data verification (SDV) has provided the backbone for monitoring, ... A model combining both on-site and remote monitoring techniques to optimise efficiency and cost.
BioCardia, Inc. has completed source data verification and finalized primary outcomes data for its Phase 3 CardiAMP HF study, which tests an autologous cell therapy for treating ischemic heart ...
Traditionally, source data verification (SDV) has provided the backbone for monitoring, but the increasing complexity and scale of modern trials require more efficient, risk-based methodologies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results